Selective T Cell Costimulation Modulator

Name
Selective T Cell Costimulation Modulator
Accession Number
DBCAT003439
Description

Not Available

Drugs
DrugDrug Description
AbataceptA disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease.
Drugs & Drug Targets
DrugTargetType
AbataceptT-lymphocyte activation antigen CD80target
AbataceptT-lymphocyte activation antigen CD86target
AbataceptCytotoxic T-lymphocyte protein 4target